Aislandi - Kiaisilandi - LYFJASTOFNUN (Icelandic Medicines Agency)

ceva santé animale* - ketoprofenum inn - stungulyf, lausn - 100 mg/ml

Aislandi - Kiaisilandi - LYFJASTOFNUN (Icelandic Medicines Agency)

reckitt benckiser healthcare (scandinavia) a/s - flurbiprofenum inn - munnsogstafla - 8,75 mg

Aislandi - Kiaisilandi - LYFJASTOFNUN (Icelandic Medicines Agency)

reckitt benckiser healthcare (scandinavia) a/s - flurbiprofenum inn - munnsogstafla - 8,75 mg

Aislandi - Kiaisilandi - LYFJASTOFNUN (Icelandic Medicines Agency)

heilsa ehf. - flurbiprofenum inn - munnsogstafla - 8,75 mg

Aislandi - Kiaisilandi - LYFJASTOFNUN (Icelandic Medicines Agency)

reckitt benckiser healthcare (scandinavia) a/s - flurbiprofenum inn - munnholsúði, lausn - 16,2 mg/ml

Umoja wa Ulaya - Kiaisilandi - EMA (European Medicines Agency)

h. lundbeck a/s - nalmefene stutt og long-term tvíhýdrat - Áfengissjúkdómar - lyf notuð í áfengismálum - selincro er ætlað til að draga úr áfengisneyslu hjá fullorðnum sjúklingum með áfengismál sem hafa mikla áhættuþætti (sjá kafla 5. 1), án líkamlegrar fráhvarfseinkenna og hver þarfnast ekki strax afeitrun. skila ætti að vera aðeins lýst er í tengslum við samfelld sálrænan stuðning áherslu á meðferð farið og draga úr áfengisneyslu. skila ætti að vera hafin aðeins í sjúklingar sem halda áfram að hafa hátt drekka-hættu stigi tvær vikur eftir fyrstu mat.

Umoja wa Ulaya - Kiaisilandi - EMA (European Medicines Agency)

teva b.v. - zoledronsýra - osteoporosis; osteitis deformans; osteoporosis, postmenopausal - lyf til að meðhöndla beinsjúkdóma - treatment of osteoporosis: , in post-menopausal women;, in men; , at increased risk of fracture including those with a recent low-trauma hip fracture. treatment of osteoporosis associated with long-term systemic glucocorticoid therapy: , in post-menopausal women;, in men; , at increased risk of fracture. meðferð gerðar voru á fyrirbyggjandi er sjúkdómur bein í fullorðnir.

Umoja wa Ulaya - Kiaisilandi - EMA (European Medicines Agency)

accord healthcare s.l.u. - doxorubicin hydrochloride, liposomal - ovarian neoplasms; sarcoma, kaposi; multiple myeloma - doxorubicin - zolsketil pegylated liposomal is a medicine used to treat the following types of cancer in adults:• breast cancer that has spread to other parts of the body in patients at risk of heart problems. zolsketil pegylated liposomal is used on its own for this disease;• advanced ovarian cancer in women whose previous treatment including a platinum-based cancer medicine has stopped working;• multiple myeloma (a cancer of the white blood cells in the bone marrow), in patients with progressive disease who have received at least one other treatment in the past and have already had, or are unsuitable for, a bone marrow transplantation. zolsketil pegylated liposomal is used in combination with bortezomib (another cancer medicine);• kaposi’s sarcoma in patients with aids who have a very damaged immune system. kaposi’s sarcoma is a cancer that causes abnormal tissue to grow under the skin, on moist body surfaces or on internal organs. zolsketil pegylated liposomal contains the active substance doxorubicin and is a ‘hybrid medicine’. this means that it is similar to a ‘reference medicine’ containing the same active substance called adriamycin. however, in zolsketil pegylated liposomal the active substance is enclosed in tiny fatty spheres called liposomes, whereas this is not the case for adriamycin.

Umoja wa Ulaya - Kiaisilandi - EMA (European Medicines Agency)

chemical works of gedeon richter plc. (gedeon richter plc.) - ganirelix acetate - reproductive techniques, assisted; ovulation induction; infertility, female - hinsveiflur og heilahimnubólur og hliðstæður - prevention of premature luteinising hormone (lh) surges in women undergoing controlled ovarian hyperstimulation (coh) for assisted reproduction techniques (art).

Umoja wa Ulaya - Kiaisilandi - EMA (European Medicines Agency)

sandoz pharmaceuticals d.d. - zoledronsýra - osteoporosis; osteitis deformans; osteoporosis, postmenopausal - lyf til að meðhöndla beinsjúkdóma - treatment of osteoporosis: , in post-menopausal women;, in men; , at increased risk of fracture, including those with a recent low-trauma hip fracture. meðferð beinbrot í tengslum við langtíma almenn sykurstera meðferð í tíðahvörf konur og menn á jókst hættan á beinbrot. meðferð gerðar voru á fyrirbyggjandi er sjúkdómur bein.